211 related articles for article (PubMed ID: 32823660)
1. Botanical Products in the Treatment and Control of Schistosomiasis: Recent Studies and Distribution of Active Plant Resources According to Affected Regions.
Duarte Galhardo de Albuquerque RD; Mahomoodally MF; Lobine D; Suroowan S; Rengasamy KR
Biology (Basel); 2020 Aug; 9(8):. PubMed ID: 32823660
[TBL] [Abstract][Full Text] [Related]
2. Schistosomiasis: Drugs used and treatment strategies.
Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
[TBL] [Abstract][Full Text] [Related]
3. Phytochemical Molluscicides and Schistosomiasis: What We Know and What We Still Need to Learn.
de Carvalho Augusto R; Mello Silva CC
Vet Sci; 2018 Nov; 5(4):. PubMed ID: 30404145
[TBL] [Abstract][Full Text] [Related]
4. Plant molluscicides: potential of Aridan, Tetrapleura tetraptera, for schistosomiasis control in Nigeria.
Adewunmi CO
Sci Total Environ; 1991 Feb; 102():21-33. PubMed ID: 2038664
[TBL] [Abstract][Full Text] [Related]
5. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
[TBL] [Abstract][Full Text] [Related]
6. Schistosoma mansoni and Biomphalaria: past history and future trends.
Morgan JA; Dejong RJ; Snyder SD; Mkoji GM; Loker ES
Parasitology; 2001; 123 Suppl():S211-28. PubMed ID: 11769285
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of using Euphorbia splendens as a molluscicide in schistosomiasis control programs.
Baptista DF; Vasconcellos MC; Lopes FE; Silva IP; Schall VT
Southeast Asian J Trop Med Public Health; 1994 Sep; 25(3):419-24. PubMed ID: 7777901
[TBL] [Abstract][Full Text] [Related]
8. Development of a natural molluscicide prototype kit (MoluSchall) for the control of schistosomiasis mansoni transmission.
Paula-Andrade C; Coelho PRS; Nascimento RAP; Mota PMPC; Romano-Silva MA; Alvarenga KAF; Schall VT; Pimenta DN; Coelho PMZ; Oliveira E
Rev Soc Bras Med Trop; 2019; 52():e20190252. PubMed ID: 31618284
[TBL] [Abstract][Full Text] [Related]
9. Urogenital schistosomiasis and associated determinant factors among senior high school students in the Dutsin-Ma and Safana Local Government Areas of Katsina State, Nigeria.
Atalabi TE; Lawal U; Akinluyi FO
Infect Dis Poverty; 2016 Aug; 5(1):69. PubMed ID: 27480058
[TBL] [Abstract][Full Text] [Related]
10. Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis.
Lai YS; Biedermann P; Ekpo UF; Garba A; Mathieu E; Midzi N; Mwinzi P; N'Goran EK; Raso G; Assaré RK; Sacko M; Schur N; Talla I; Tchuenté LA; Touré S; Winkler MS; Utzinger J; Vounatsou P
Lancet Infect Dis; 2015 Aug; 15(8):927-40. PubMed ID: 26004859
[TBL] [Abstract][Full Text] [Related]
11. Molluscicides in schistosomiasis control.
McCullough FS; Gayral P; Duncan J; Christie JD
Bull World Health Organ; 1980; 58(5):681-9. PubMed ID: 6975179
[TBL] [Abstract][Full Text] [Related]
12. Schistosomes, snails and climate change: Current trends and future expectations.
Stensgaard AS; Vounatsou P; Sengupta ME; Utzinger J
Acta Trop; 2019 Feb; 190():257-268. PubMed ID: 30261186
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Study of Natural Products with Anti-Schistosoma Activity.
Akachukwu I; Olubiyi OO; Kosisochukwu A; John MC; Justina NN
Curr Comput Aided Drug Des; 2017; 13(2):91-100. PubMed ID: 28103771
[TBL] [Abstract][Full Text] [Related]
14. Schistosomiasis chemotherapy.
Thétiot-Laurent SA; Boissier J; Robert A; Meunier B
Angew Chem Int Ed Engl; 2013 Jul; 52(31):7936-56. PubMed ID: 23813602
[TBL] [Abstract][Full Text] [Related]
15. [Strengthening the research on novel molluscicides to accelerate the progress towards elimination of schistosomiasis].
Yi-Xin H
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2019 May; 31(2):107-108. PubMed ID: 31184037
[No Abstract] [Full Text] [Related]
16. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
17. Schistosomiasis epidemiology and control: how did we get here and where should we go?
Sturrock RF
Mem Inst Oswaldo Cruz; 2001; 96 Suppl():17-27. PubMed ID: 11586422
[TBL] [Abstract][Full Text] [Related]
18. Biotechnological advances in the diagnosis, species differentiation and phylogenetic analysis of Schistosoma spp.
Zhao GH; Li J; Blair D; Li XY; Elsheikha HM; Lin RQ; Zou FC; Zhu XQ
Biotechnol Adv; 2012; 30(6):1381-9. PubMed ID: 22366555
[TBL] [Abstract][Full Text] [Related]
19. Socioenvironmental factors associated with Schistosoma mansoni infection and intermediate hosts in an urban area of northeastern Brazil.
Calasans TAS; Souza GTR; Melo CM; Madi RR; Jeraldo VLS
PLoS One; 2018; 13(5):e0195519. PubMed ID: 29718924
[TBL] [Abstract][Full Text] [Related]
20. Implementation of human schistosomiasis control: Challenges and prospects.
Fenwick A; Rollinson D; Southgate V
Adv Parasitol; 2006; 61():567-622. PubMed ID: 16735173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
